We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Rigel Pharmaceuticals, Inc. (RIGL)
An SI Board Since November 2000
Posts SubjectMarks Bans Symbol
566 41 0 RIGL
Emcee:  scaram(o)uche Type:  Unmoderated
This one will be fun......

Rigel Pharmaceuticals Announces Pricing of Initial Public Offering

SOUTH SAN FRANCISCO, Calif., Nov. 28 /PRNewswire/ --
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the pricing of its
initial public offering of 5,000,000 shares of common stock at a price of
$7.00 per share. Gross proceeds to Rigel will be $35 million. All of the
shares are being offered by the Company. Rigel has granted the underwriters an
option to purchase up to an additional 750,000 shares of common stock to cover
over-allotments, if any. The offering is being made through an underwriter
group led by Morgan Stanley Dean Witter, with Lehman Brothers and Robertson
Stephens co-managing the offering. Concurrent with this initial public
offering, Novartis is purchasing an additional 1,428,571 shares of the
Company's common stock through a private placement at $7.00 per share.
Rigel uses post-genomics combinatorial biology technology to discover
novel drug targets. Post-genomics combinatorial biology technology is designed
to identify molecules which play an important role in regulating a human
cell's response to disease by testing a very large number of proteins in a
very large number of cells to determine which proteins will change the cell's
response to the disease. Rigel currently has programs in asthma/allergy,
autoimmunity, transplant rejection, rheumatoid arthritis, inflammatory bowel
disease, cancerous tumor growth and hepatitis C. Rigel has a collaboration
with Pfizer Inc. and multi-year collaborations with Cell Genesys, Inc.,
Janssen Pharmaceutica N.V. and Novartis Pharma A.G. Rigel is based in South
San Francisco, California.
A registration statement relating to these securities was filed with and
has been declared effective by the U.S. Securities and Exchange Commission.
Copies of the final prospectus related to the offering may be obtained from
Morgan Stanley Dean Witter, 1585 Broadway, New York, NY 10036, 212-761-4000;
Lehman Brothers, Three World Financial Center, 15th floor, 200 Vesey Street,
New York, NY 10285, 212-526-7000; or Robertson Stephens, 590 Madison Avenue,
36th floor, New York, NY 10022, 212-319-8900.
This press release shall not constitute an offer to sell nor a
solicitation of an offer to buy nor shall there be any sale of these
securities in any state in which such an offer, solicitation or sale would be
unlawful prior to the registration or qualification under the securities laws
of any such state.

SOURCE Rigel Pharmaceuticals, Inc.
Web Site:
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
566Sold about 1/2 of a very over-weight position -- got rid of all my $3 handles...mopgcw-8/19/2020
565Did you bail?Steve Lokness-7/15/2020
564Man this took forevermopgcw17/14/2020
563Rigel Pharmaceuticals, Inc. [graphic]Julius Wong-9/3/2018
562Chuckle, yea, still holding this one and back in the black. took some chips themopgcw-4/24/2018
561Hadn't owned it since forever. But company always seemed to be big-science,scaram(o)uche-4/18/2018
560As you probably know, but for others who weren't watching today's jackasscaram(o)uche-4/13/2018
559News that made Rigel stock pop was a mistake, Rigel says marketwatch.comJulius Wong-4/12/2018
558Anyone watching the drama today will have seen the refilling bid at $4. Someonescaram(o)uche-4/12/2018
557Bullish crossover in MACD and Stochastic oscillator. [graphic]hollyhunter-8/7/2017
556Maybe time to watch more closely....if the past pattern continues..... [graphicThe Ox-8/4/2017
555Finally some good news....still holding. mopgcw-8/31/2016
554RIGL is among my best performing stocks today.<g> It is in 3rd place % wisJibacoa-3/31/2015
553fwiw: Jefferies starts coverage with a Buy and target of $10.00 citing favorablemopgcw-3/31/2015
552Rigel Pharmaceuticals (RIGL) Bounce Warranted, Says Wells Fargo 10:19 AM ET, 02/mopgcw-2/23/2015
551I'm with you here. This has been a hard story for me. The announcement looksSteve Lokness-8/15/2014
550alas another setback...the moment I sell they will hit a homerun...mopgcw-8/13/2014
549up 10% on this?? Rigel Pharma (RIGL) Reports Publication of Recent R118 Resultsmopgcw-3/7/2014
548bvf dumps.mopgcw-11/20/2013
547trading a little over cash, R333 and R348, and last shot on goal from 788.mopgcw-8/26/2013
546What causes you to be interested at the current price? They don't seem to haD.Lu-8/26/2013
545fwiw, averaging down here at 3.15...keep it interesting... hope all is well witmopgcw-8/26/2013
544R343 whiffs in asthma, and development of the molecule is being stopped. New altuck-8/26/2013
543fwiw, bottom fishing here at $3.75.mopgcw-6/14/2013
542Piper downgraded Rigel Pharmaceuticals to Neutral from Overweight following the mopgcw-6/4/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):